$3.55 Billion is the total value of RTW INVESTMENTS, LP's 77 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RCKT | Rocket Pharmaceuticals Inc | $351,885,000 | +50.0% | 16,812,491 | 0.0% | 9.90% | -1.9% | |
| ALNY | Alnylam Pharmaceuticals Inc | $249,068,000 | +36.1% | 1,681,645 | 0.0% | 7.01% | -11.1% | |
| STOK | Stoke Therapeutics Inc | $84,459,000 | +4.1% | 3,544,248 | 0.0% | 2.38% | -32.0% | |
| ESTA | Establishment Labs Hldgs Inc | $43,322,000 | +29.3% | 2,319,138 | 0.0% | 1.22% | -15.5% | |
| APYX | Apyx Med Corp | $18,822,000 | +54.6% | 3,391,279 | 0.0% | 0.53% | +1.1% | |
| MIST | Milestone Pharmaceuticals In | $16,311,000 | +105.4% | 4,315,102 | 0.0% | 0.46% | +34.2% | |
| MDXG | MiMedx Group Inc | $14,582,000 | +54.7% | 2,700,320 | 0.0% | 0.41% | +1.0% | |
| ABUS | Arbutus Biopharma Corp | $12,502,000 | +80.2% | 6,869,281 | 0.0% | 0.35% | +17.7% | |
| TMDX | Transmedics Group Inc | $9,019,000 | +48.4% | 503,266 | 0.0% | 0.25% | -3.1% | |
| ITMR | Itamar Med Ltdsponsored ads | $8,504,000 | +57.9% | 457,218 | 0.0% | 0.24% | +3.0% | |
| ARGX | argenx SEsponsored adr | $7,152,000 | +71.0% | 31,752 | 0.0% | 0.20% | +11.7% | |
| INMD | Inmode Ltd | $7,080,000 | +31.7% | 250,000 | 0.0% | 0.20% | -13.9% | |
| BWAY | Brainsway Ltdsponsored ads | $6,556,000 | -25.4% | 1,107,420 | 0.0% | 0.18% | -51.3% | |
| LSACU | Lifesci Acquisition Corpunit 03/31/2025 | $5,500,000 | +10.0% | 500,000 | 0.0% | 0.16% | -27.9% | |
| PHGE | Biomx Inc | $3,312,000 | -21.1% | 600,000 | 0.0% | 0.09% | -48.6% | |
| PSNL | Personalis Inc | $3,307,000 | +60.7% | 255,000 | 0.0% | 0.09% | +4.5% | |
| PROF | Profound Med Corp | $2,951,000 | +73.9% | 174,193 | 0.0% | 0.08% | +13.7% | |
| FLGT | Fulgent Genetics Inc | $1,200,000 | +48.7% | 75,000 | 0.0% | 0.03% | -2.9% | |
| MOTS | Motus Gi Hldgs Inc | $1,024,000 | +95.8% | 775,640 | 0.0% | 0.03% | +26.1% | |
| VRAY | Viewray Inc | $336,000 | -10.4% | 150,000 | 0.0% | 0.01% | -43.8% | |
| PHGEWS | BiomX Inc*w exp 10/16/202 | $287,000 | -20.3% | 600,000 | 0.0% | 0.01% | -46.7% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 36 | Q3 2023 | 19.7% |
| MASIMO CORP | 32 | Q3 2023 | 5.8% |
| LA JOLLA PHARMACEUTICAL CO | 31 | Q2 2022 | 9.7% |
| REGENXBIO INC | 30 | Q4 2022 | 10.8% |
| AGENUS INC | 29 | Q2 2022 | 9.0% |
| PTC THERAPEUTICS INC | 28 | Q3 2023 | 12.8% |
| DICERNA PHARMACEUTICALS INC | 28 | Q3 2021 | 10.8% |
| MIRATI THERAPEUTICS INC | 26 | Q3 2023 | 6.2% |
| ARGENX SE | 26 | Q3 2023 | 5.3% |
| VERICEL CORP | 24 | Q3 2023 | 3.9% |
View RTW INVESTMENTS, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | September 19, 2023 | 18,188,457 | - |
| ALLURION TECHNOLOGIES, INC. | August 11, 2023 | 3,457,707 | 7.4% |
| Orchestra BioMed Holdings, Inc. | May 05, 2023 | 5,620,645 | 15.7% |
| Renovacor, Inc.Sold out | April 05, 2023 | 0 | - |
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Aptevo Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ASLAN Pharmaceuticals LtdSold out | February 14, 2023 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| BELLUS Health Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Clearside Biomedical, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View RTW INVESTMENTS, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-03-01 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View RTW INVESTMENTS, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.